๐ฐ Use Listing News
Page 10 - Use Listing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Use Listing. Real-time updates on events, politics, business and more.
December 22, 2021
- - WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 an...
December 22, 2021
/CNW/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious...
December 22, 2021
Download logoA nationwide campaign to vaccinate 16.5 million children under age five with novel oral polio vaccine type 2 (nOPV2) began this week in
December 22, 2021
- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and
December 21, 2021
The Central Drugs Standard Control Organisation (CDSCO) has approved the extension of Bharat Biotech's COVID-19 vaccine Covaxin's shelf life up to 12 months from the date of manufacture, the vaccine-maker said. โThis approval of shelf life extension is based on the availability of additional stability data, which was submitted to CDSCO. With the shelf life extension, hospitals
December 21, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 21, 2021
Taipei, Dec. 21 (CNA) Digital COVID-19 certificates issued by Taiwan will be accepted as equivalent to the EU Digital COVID Certificate from Wednesday.
December 21, 2021
- WHO Strategic Advisory Group of Experts on Immunization (SAGE) recommends primary two-dose vaccination series of NVX-CoV2373 in persons aged 18 and older - SAGE recommends additional
December 21, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...
December 21, 2021
/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...